Article info
Hepatology
Original article
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
- Correspondence to Hongyang Wang and Jin Ding, International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, 225 Changhai Road, 200438 Shanghai, China; hywangk{at}vip.sina.com, dingjin1103{at}163.com
Citation
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
Publication history
- Received August 20, 2018
- Revised April 25, 2019
- Accepted April 26, 2019
- First published May 22, 2019.
Online issue publication
September 06, 2019
Article Versions
- Previous version (22 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.